Revive Therapeutics Ltd. (31R)
Munich
0.0175
0.00 (0.00%)
Delayed Data
Oct 14, 2026, 06:00 AM
Day's Range
0.01750.0175
52 wk Range
0.000500.0495
Financial Statements - 31R - Revive Therapeutics Ltd.
Revenue
0
Net Income
-11.01M▼ 218.0%
EBITDA
-1.65M▲ 17.0%
Free Cash Flow
-767.65K▲ 62.1%
Income Statement
| Period Ending | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -1.64M | -2.02M | -5.52M | -17.83M | -18.59M | -3.68M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -9.36M | -1.46M | -864.50K | -26.70K | -1.54M | -1.65M |
| Pre Tax Income | -11.01M | -3.46M | -6.32M | -17.80M | -20.11M | -5.38M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -11.01M | -3.46M | -6.32M | -17.80M | -20.11M | -5.38M |
| EPS Basic | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
| EPS Diluted | -0.03 | -0.01 | -0.02 | -0.06 | -0.08 | -0.05 |
| Basic Shares Outstanding | 419.71M | 234.49M | 502.84M | 473.79M | 396.34M | 158.36M |
| Diluted Shares Outstanding | 419.71M | 234.49M | 502.84M | 473.79M | 396.34M | 158.36M |
| Ebit | -11.01M | -3.45M | -6.27M | -17.74M | -20.03M | -5.29M |
| Ebitda | -1.65M | -1.98M | -5.41M | -17.71M | -18.49M | -4.81M |
| Net Income Continuous Operations | -11.01M | -3.46M | -6.32M | -17.80M | -20.11M | -5.38M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
